Ankesh Nigam, MD | Authors

CVS PHARMACY

Articles

Neoadjuvant Strategies for Pancreatic Cancer

June 01, 2001

We have made much progress over the past 30 years in the surgical management of pancreatic cancer, and perioperative mortality rates are low in centers with experience in the treatment of this disease. However, surgical resection is clearly limited in achieving local and systemic control of pancreatic cancer, and chemoradiation will likely become a part of any successful pancreatic cancer treatment program.